ClinicalTrials.govpublic full text
Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
thrombosis, bleeding, coronary artery disease (cad), coronary heart disease, dual antiplatelet therapy, multi-omics, biomarkers, risk prediction model, machine learning, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906736
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.